Clinical Trial Update: Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L]) [Phase 4]

View source ↗

Summary

Phase 4 trial of Luveris (lutropin alfa) in women with hypogonadotropic hypogonadism was terminated. Results were posted in July 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism

Drugs mentioned

• Luveris (lutropin alfa)

Snippet

Sponsor: EMD Serono | Conditions: Hypogonadotropic Hypogonadism | Phase 4 | Status: TERMINATED | Results posted: 2013-07-12